Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers

The use of combined hormonal contraceptives has been reported to increase the level of C-reactive protein (CRP). We assessed the effect of hormonal contraceptive use on inflammatory cytokines including CRP, monocyte chemotactic protein-1, soluble tumor necrosis factor (sTNF), interleukin-6 (IL-6), a...

Full description

Saved in:
Bibliographic Details
Main Authors: Afshin A. Divani, Xianghua Luo, Yvonne H. Datta, James D. Flaherty, Angela Panoskaltsis-Mortari
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/379501
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562860145770496
author Afshin A. Divani
Xianghua Luo
Yvonne H. Datta
James D. Flaherty
Angela Panoskaltsis-Mortari
author_facet Afshin A. Divani
Xianghua Luo
Yvonne H. Datta
James D. Flaherty
Angela Panoskaltsis-Mortari
author_sort Afshin A. Divani
collection DOAJ
description The use of combined hormonal contraceptives has been reported to increase the level of C-reactive protein (CRP). We assessed the effect of hormonal contraceptive use on inflammatory cytokines including CRP, monocyte chemotactic protein-1, soluble tumor necrosis factor (sTNF), interleukin-6 (IL-6), and soluble CD40 ligand. We used 79 female subjects (19 to 30 years old) who were combined oral contraceptives users (n=29), combined vaginal contraceptive users (n=20), and nonusers (n=30) with CRP values of ≤1 (n=46) or ≥3 (n=33). Information on medical history, physical activities, and dietary and sleeping habits were collected. Both oral and vaginal contraceptive users had higher levels of CRP (P<0.0001), compared to nonusers. Only oral contraceptive users exhibited elevated sCD40L (P<0.01). When comparing the groups with CRP ≤ 1 and CRP ≥ 3, levels of IL-6 and sTNF-RI were positively correlated with CRP among oral contraceptive users. We did not observe the same elevation for other inflammatory biomarkers for the CRP ≥ 3 group among vaginal contraceptive users. The clear cause of elevation in CRP level due to the use of different hormonal contraceptive formulations and methods is not well understood. Longitudinal studies with larger sample size are required to better assess the true cause of CRP elevation among hormonal contraceptive users.
format Article
id doaj-art-243d610465b54e89b865133d85d1bd74
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-243d610465b54e89b865133d85d1bd742025-02-03T01:21:31ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/379501379501Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood BiomarkersAfshin A. Divani0Xianghua Luo1Yvonne H. Datta2James D. Flaherty3Angela Panoskaltsis-Mortari4Department of Neurology, University of Minnesota, Minneapolis, MN 55455, USADivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USADivision of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USADivision of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USABlood and Marrow Transplantation Division, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USAThe use of combined hormonal contraceptives has been reported to increase the level of C-reactive protein (CRP). We assessed the effect of hormonal contraceptive use on inflammatory cytokines including CRP, monocyte chemotactic protein-1, soluble tumor necrosis factor (sTNF), interleukin-6 (IL-6), and soluble CD40 ligand. We used 79 female subjects (19 to 30 years old) who were combined oral contraceptives users (n=29), combined vaginal contraceptive users (n=20), and nonusers (n=30) with CRP values of ≤1 (n=46) or ≥3 (n=33). Information on medical history, physical activities, and dietary and sleeping habits were collected. Both oral and vaginal contraceptive users had higher levels of CRP (P<0.0001), compared to nonusers. Only oral contraceptive users exhibited elevated sCD40L (P<0.01). When comparing the groups with CRP ≤ 1 and CRP ≥ 3, levels of IL-6 and sTNF-RI were positively correlated with CRP among oral contraceptive users. We did not observe the same elevation for other inflammatory biomarkers for the CRP ≥ 3 group among vaginal contraceptive users. The clear cause of elevation in CRP level due to the use of different hormonal contraceptive formulations and methods is not well understood. Longitudinal studies with larger sample size are required to better assess the true cause of CRP elevation among hormonal contraceptive users.http://dx.doi.org/10.1155/2015/379501
spellingShingle Afshin A. Divani
Xianghua Luo
Yvonne H. Datta
James D. Flaherty
Angela Panoskaltsis-Mortari
Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
Mediators of Inflammation
title Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
title_full Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
title_fullStr Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
title_full_unstemmed Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
title_short Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
title_sort effect of oral and vaginal hormonal contraceptives on inflammatory blood biomarkers
url http://dx.doi.org/10.1155/2015/379501
work_keys_str_mv AT afshinadivani effectoforalandvaginalhormonalcontraceptivesoninflammatorybloodbiomarkers
AT xianghualuo effectoforalandvaginalhormonalcontraceptivesoninflammatorybloodbiomarkers
AT yvonnehdatta effectoforalandvaginalhormonalcontraceptivesoninflammatorybloodbiomarkers
AT jamesdflaherty effectoforalandvaginalhormonalcontraceptivesoninflammatorybloodbiomarkers
AT angelapanoskaltsismortari effectoforalandvaginalhormonalcontraceptivesoninflammatorybloodbiomarkers